These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28339386)

  • 21. Regulators faulted for inadequate compounding pharmacy oversight.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
    [No Abstract]   [Full Text] [Related]  

  • 22. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 23. Compounding errors.
    Drazen JM; Curfman GD; Baden LR; Morrissey S
    N Engl J Med; 2012 Dec; 367(25):2436-7. PubMed ID: 23134355
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 25. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS.
    Pritchett J; Mixon W; O'Connell K
    Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug compounding, drug safety, and the first amendment.
    Dresser R
    Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P; Pantano D; Gennari CG; Casiraghi A
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
    Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
    [No Abstract]   [Full Text] [Related]  

  • 31. Battles over compounding from bulk drugs move forward.
    Clark A
    J Am Vet Med Assoc; 2005 Jul; 227(1):9-10. PubMed ID: 16013529
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulating Compounding Pharmacies.
    Noble A
    NCSL Legisbrief; 2016 Nov; 24(42):1-2. PubMed ID: 27911513
    [No Abstract]   [Full Text] [Related]  

  • 33. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NABP to inspect compounding pharmacies.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(2):88-90. PubMed ID: 23292258
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 37. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
    Pritchett J; McCrory G; Kraemer C; Jensen B; Allen LV
    Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The drug quality and security act: how will it change pharmacy?
    Soukup BJ
    Consult Pharm; 2014; 29(5):352. PubMed ID: 25203978
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 40. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.